Development and validation of a new, sensitive immunochemical assay for O⁶-methylguanine in DNA and its application in a population study.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Kyrtopoulos, Soterios A.
MetadataShow full item record
AbstractInvestigations of the presence of the precarcinogenic DNA adduct O⁶-methylguanine (O6-meG) in humans and its association with exposure or cancer risk have been hindered by the absence of analytic methods of adequate sensitivity and throughput. We report the development, validation, and application of an ELISA-type assay for O6-meG appropriate for large-scale population studies.
In the new analytic method, restriction enzymes are used to digest DNA to fragments of size expected to contain no more than one O6-meG residue. Anti-adduct antisera are used to transfer O6-meG-containing fragments to a solid surface, where they are detected using anti-ssDNA antisera, the high ratio of normal nucleotides to adducts providing a strong signal enhancement.
An assay with a limit of detection of 1.5 adducts/10⁹ nucleotides using 10 μg of DNA, a dynamic range of approximately two orders of magnitude and satisfactory precision and accuracy characteristics was established and validated. Analysis of samples from 120 subjects from the Rhea mother-child cohort in Crete led to the detection of O6-meG in 70% of maternal and 50% of cord blood buffy coat samples at mean levels of 0.65 and 0.38 adducts/10⁸ nucleotides, respectively.
The frequent observation of O6-meG in human DNA is compatible with dietary compounds (e.g. N-nitroso compounds or their precursors), or endogenous processes being responsible for the formation of this adduct.
The new assay opens the way for large-scale population studies of O6-meG as a biomarker of exposure or risk. The approach used in this assay can, in principle, be extended to any DNA adduct for which suitable antisera are available.
CitationCancer Epidemiol. Biomarkers Prev. 2011, 20 (1):82-90
SponsorsResearch in this article was supported by contracts from the European Union (Network of Excellence ECNIS—"Environmental cancer risk, nutrition and individual susceptibility," contract number FOOD-CT-2005-513943;
- A novel, sensitive assay for O6-methyl- and O6-ethylguanine in DNA, based on repair by the enzyme O6-alkylguanine-DNA-alkyltransferase in competition with an oligonucleotide containing O6-methylguanine.
- Authors: Souliotis VL, Kyrtopoulos SA
- Issue date: 1989 Dec 15
- Ubiquitous presence of O6-methylguanine in human peripheral and cord blood DNA.
- Authors: Georgiadis P, Samoli E, Kaila S, Katsouyanni K, Kyrtopoulos SA
- Issue date: 2000 Mar
- Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair.
- Authors: Souliotis VL, Kaila S, Boussiotis VA, Pangalis GA, Kyrtopoulos SA
- Issue date: 1990 May 1
- Reduction of O6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated with O6-alkylguanines.
- Authors: Dolan ME, Morimoto K, Pegg AE
- Issue date: 1985 Dec
- Production of a high-affinity monoclonal antibody specific for 7-(benzo[alpha]pyren-6-yl) guanine and its application in a competitive enzyme-linked immunosorbent assay.
- Authors: Casale GP, Rogan EG, Stack D, Devanesan P, Cavalieri EL
- Issue date: 1996 Sep